HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Many of our clients in Korea and China export their products to Southeast Asia and the Middle East, regions with islamic community. With 60-70% of the world’s Muslim population living in Asia, this certification has become a growing demand from our partners.
👉 Discover more by reading our Press Release
At HTL Biotechnology, we are dedicated to providing high-quality products that respect the cultural standards and meet the regulatory standards of all our customers, wherever they are.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.